InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
4
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-23.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Watson W. Mark, Director. Officer active across 3 companies, notably Vaxart, Inc.. Cumulatively, 14 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €36k. Activity tracked since 19 May 2021. The latest transaction was filed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Watson W. Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
39,400 股0Common StockSEC:0001437749-26-023808:0
15,000 股@ US$0.410.0032% mcap50.0% 占其流量Common StockSEC:0001437749-25-037051:0
标准退出：2026年2月15日 (T+90)
10,000 股@ US$0.4059.8% 占其流量Common StockSEC:0001437749-25-024250:0
标准退出：2025年10月27日 (T+90)
16,000 股0Common StockSEC:0001437749-25-020571:0
20,000 股@ US$0.678933.7% 占其流量Common StockSEC:0001437749-24-020694:0
标准退出：2024年9月16日 (T+90)
16,000 股0Common StockSEC:0001437749-24-020095:0
7,375 股0Common StockSEC:0001437749-23-021507:0
20,000 股@ US$0.75738.0% 占其流量Common StockSEC:0001437749-22-029843:0
标准退出：2023年3月28日 (T+90)
14,750 股0Common StockSEC:0001437749-22-019446:0
90,663 股0Common StockSEC:0001103021-22-000075:0
7,684 股0Common StockSEC:0001103021-22-000025:0
13,491 股0Common StockSEC:0001127602-21-024398:0
30,000 股0Common StockSEC:0001103021-21-000074:0
694 股@ US$41.43100.0% 占其流量Common StockSEC:0001127602-21-017319:0
14 条申报中的 14 条
About Watson W. Mark
Mark Watson is a Director at Vaxart, Inc., SYKES ENTERPRISES INC, and BIODELIVERY SCIENCES INTERNATIONAL INC. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His diverse experience is valuable in guiding these organizations towards their objectives.
